naproxen sodium
Generic: naproxen sodium
Labeler: spirit pharmaceuticals,llcDrug Facts
Product Profile
Brand Name
naproxen sodium
Generic Name
naproxen sodium
Labeler
spirit pharmaceuticals,llc
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
Active Ingredients
naproxen sodium 220 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68210-4096
Product ID
68210-4096_2a8235d0-4618-0572-e063-6394a90a0d1a
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA091353
Listing Expiration
2026-12-31
Marketing Start
2020-07-02
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
682104096
Hyphenated Format
68210-4096
Supplemental Identifiers
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen sodium (source: ndc)
Generic Name
naproxen sodium (source: ndc)
Application Number
ANDA091353 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 220 mg/1
Packaging
- 365 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-4096-1)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2a8235d0-4618-0572-e063-6394a90a0d1a", "openfda": {"unii": ["9TN87S3A3C"], "spl_set_id": ["a690dc39-95f2-4853-a291-05d7dc9a1551"], "manufacturer_name": ["SPIRIT PHARMACEUTICALS,LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "365 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-4096-1)", "package_ndc": "68210-4096-1", "marketing_start_date": "20200702"}], "brand_name": "NAPROXEN SODIUM", "product_id": "68210-4096_2a8235d0-4618-0572-e063-6394a90a0d1a", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "68210-4096", "generic_name": "NAPROXEN SODIUM", "labeler_name": "SPIRIT PHARMACEUTICALS,LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "NAPROXEN SODIUM", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA091353", "marketing_category": "ANDA", "marketing_start_date": "20200702", "listing_expiration_date": "20261231"}